News & Publications

On July 21, 2021, Atom Computing, a fast-growing quantum computing startup, announced it has raised $15 million in Series A funding. 

On August 11, 2021, GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology, announced it has closed a Series A financing generating immediate proceeds of $157 million.

On July 26, 2021, Embark Veterinary, Inc., the top rated provider of dog DNA tests, announced that it secured $75 million in a Series B funding round led by SoftBank.

On May 20, 2021, Workrise (formerly RigUp), the leading workforce management platform for the skilled trades, announced it has raised a $300 million Series E round. As it enlarges its footprint, Workrise offers trade workers access to training that equips them for energy and infrastructure jobs on the rise.

Immuta, the leading provider of cloud data access control, announced that it has secured $90 million in Series D funding.

On May 11, 2021, Acquco, a platform focused on acquiring third-party sellers on Amazon, announced that it has closed a $160 million Series A round.

On April 20, 2021, Catch&Release, a creative technology company for the next generation of commercial production, announced it has secured $14 million in Series A funding to help brands break free from the limitations of stock photography.

On May 4, 2021, Datanomix, leading vendor of production intelligence software for industrial manufacturers, announced it has raised $6 million in Series A funding.

WilmerHale’s annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

The 2021 Venture Capital Report offers an in-depth US venture capital market review and outlook, including industry and regional breakdowns, as well as insights on a number of key topics.

ExecOnline, the pioneer of online leadership development for enterprises, announced a Series D funding round of $45 million led by OMERS Growth Equity.

On April 6, 2021, Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and treatment of metastatic cancer, announced the extension of its original $12 million seed round to a total of $44 million.

In 2020, we served as counsel in more than 200 venture financings raising in excess of $10 billion, including some of the largest and most prominent deals of the year. Since 2010, we have handled approximately 2,700 venture financings with total proceeds in excess of $48 billion.

On February 24, 2021, Xilio Therapeutics, a biotechnology company developing potent, tumor-selective immunotherapies for patients with cancer, announced the successful closing of a $95 million Series C financing round.

On February 9, 2021, WizeHire, a user-friendly, effective hiring solution for small businesses, announced the closing of $7.5 million in Series A funding.